Is Belite Bio, Inc (BLTE) a Buy, Sell, or Hold?
NASDAQ : BLTE
Belite Bio, Inc — Analyst Ratings
$155.6 USD
-$0.35 (-0.22%)
- Volume
- 187.35K
- Average Volume
- 194.3K
- Market Capitalization
- $6.24B
- P/E Ratio
- -61.02
- Dividend Yield
- 0.00%
- Price Target
- $216.00
- Year High
- $200.00
- Year Low
- $60.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $33.71
Analyst Consensus Summary
Consensus Rating
Strong Sell
6 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-28.0%
vs Current Price
Price Target
$216.00
Average TargetPrice Target Range
Lowest Target
$200.00
-22.2% DOWNSIDE
Average Target
$216.00
Median Estimate
Highest Target
$217.00
-28.3% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 6
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 6 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Mizuho Securities | Graig Suvannavejh | $215 | $137.3 | 2026-05-26 05:50 AM | 56.6% |
| H.C. Wainwright | Yi Chen | $200 | $171.51 | 2026-03-04 06:41 AM | 16.6% |
| Mizuho Securities | Graig Suvannavejh | $223 | $173.91 | 2026-02-19 07:17 AM | 28.2% |
| Mizuho Securities | Graig Suvannavejh | $194 | $154.02 | 2025-12-02 05:11 AM | 26.0% |